HR2319-119

What This Bill Does

The Women and Lung Cancer Research and Preventive Services Act of 2025 directs the Health and Human Services Secretary, in consultation with the Defense Secretary and Veterans Affairs Secretary, to conduct an interagency review on lung cancer in women and underserved populations. The review must evaluate existing research and opportunities to accelerate research on lung cancer in women, research on lung cancer in underserved populations that meet U.S. Preventive Services Task Force screening criteria, access to lung cancer preventive services, and public awareness and education campaigns. The review and recommendations must examine previous research outcomes, current federal research activities, and knowledge gaps across federal agencies. It must identify collaborative, interagency, multidisciplinary, and innovative research opportunities, including work on environmental and genomic factors tied to lung cancer in women and advances in imaging technology and techniques for risk assessment, diagnosis, treatment, and simultaneous use of other preventive services. It also must identify opportunities for a national lung cancer screening strategy and a national education campaign on lung cancer in women and underserved populations. HHS must report to Congress within two years.

Who Benefits and How

Women at risk of lung cancer benefit because federal agencies must identify knowledge gaps, environmental and genomic research opportunities, and ways to accelerate research focused on women. Underserved populations eligible for lung cancer screening benefit from attention to screening access and preventive services. Lung cancer researchers benefit from a federal review that can highlight collaborative and multidisciplinary research opportunities. Imaging technology developers benefit from federal attention to improving risk assessment, diagnosis, treatment, and preventive-service coordination. Public health educators benefit from possible national awareness campaign recommendations. Congress benefits from a two-year report on federal research gaps and screening strategy options.

Who Bears the Burden and How

The HHS Secretary must lead the interagency review, gather federal research information, identify knowledge gaps, develop recommendations, and report to Congress. The Defense Secretary and Veterans Affairs Secretary must consult on research and preventive-service opportunities affecting service members, veterans, and military health populations. Federal research agencies must inventory previous research outcomes and current activities. Public health program staff must evaluate screening access and national education campaign options. Agencies working on imaging, genomics, and preventive services must coordinate across research silos.

Key Provisions

• Requires an HHS-led interagency review on lung cancer in women and underserved populations.
• Requires consultation with the Department of Defense and Department of Veterans Affairs.
• Requires review of previous research outcomes, current federal research, and knowledge gaps.
• Directs attention to environmental and genomic factors in lung cancer among women.
• Requires evaluation of imaging technology and techniques for risk assessment, diagnosis, treatment, and preventive services.
• Requires opportunities for a national lung cancer screening strategy and public education campaign.
• Requires HHS to report to Congress within two years.